Abstract
A detailed casenote review was performed on 55 patients registered with testicular non-seminomatous germ cell tumours (NSGCT) between 1983 and 1988 under the Scottish Cancer Registration Scheme and who had died by 1992. Details of all aspects of clinical management relating to their NSGCT and death details were extracted and summarised. An assessment was made on whether the patients' management had been optimal. An analysis of 5 year survival rates by the five Scottish oncology centres demonstrated significant differences between centres (range 70.4-94.2; chi 2 = 14.46, d.f. = 4, P = 0.006). Some patients in all centres were assessed as having received suboptimal treatment, but two centres performed less well than the other three. There is a suggestion that the number of patients treated suboptimally decreases with increasing number of patients seen, but this does not reach statistical significance.
Highlights
Eighty per cent of these died within 3 years of starting treatment with all but two cases dying within 5 years
These two cases survived 7.9 and 8.6 years, both dying of their disease
Two deaths were excluded from the casenote review
Summary
A casenote, and where necessary radiological reviw, was performed on all new testicular NSGCT cancer registrations between 1983 and 1988, with a date of death recorded before 31 December 1992. Details of surgery, radiotherapy, and chemotherapy, patient compliance. As detailed on death certificates, were obtained from the Registrar General for Scotland for all cases audited. An assessment of the appropriateness of treatment and comments on any aspect of treatment that might have adversely affected the patient's outcome was made by the reviewing clinician, who was from a different centre to where the patient had been treated.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
